Cargando…

Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations

Hematopoietic progenitor kinase 1 (HPK1) is a negative regulator of T cell receptor, which has been regarded as a potential target for immunotherapy. Yu et al. observed the off-target effect of the high-throughput screening HPK1 kinase inhibitor hits on JAK1 kinase. The off-target effect is usually...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Huizhen, Tang, Chunchao, Pan, Yiting, Yao, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916865/
https://www.ncbi.nlm.nih.gov/pubmed/36768974
http://dx.doi.org/10.3390/ijms24032649
_version_ 1784886230170730496
author Ge, Huizhen
Tang, Chunchao
Pan, Yiting
Yao, Xiaojun
author_facet Ge, Huizhen
Tang, Chunchao
Pan, Yiting
Yao, Xiaojun
author_sort Ge, Huizhen
collection PubMed
description Hematopoietic progenitor kinase 1 (HPK1) is a negative regulator of T cell receptor, which has been regarded as a potential target for immunotherapy. Yu et al. observed the off-target effect of the high-throughput screening HPK1 kinase inhibitor hits on JAK1 kinase. The off-target effect is usually due to the lack of specificity of the drug, resulting in toxic side effects. Therefore, exploring the mechanisms to selectively inhibit HPK1 is critical for developing effective and safe inhibitors. In this study, two indazole compounds as HPK1 inhibitors with different selectivity towards JAK1 were used to investigate the selectivity mechanism using multiple computational methods, including conventional molecular dynamics simulations, binding free energy calculations and umbrella sampling simulations. The results indicate that the salt bridge between the inhibitor and residue Asp101 of HPK1 favors their selectivity towards HPK1 over JAK1. Information obtained from this study can be used to discover and design more potent and selective HPK1 inhibitors for immunotherapy.
format Online
Article
Text
id pubmed-9916865
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99168652023-02-11 Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations Ge, Huizhen Tang, Chunchao Pan, Yiting Yao, Xiaojun Int J Mol Sci Article Hematopoietic progenitor kinase 1 (HPK1) is a negative regulator of T cell receptor, which has been regarded as a potential target for immunotherapy. Yu et al. observed the off-target effect of the high-throughput screening HPK1 kinase inhibitor hits on JAK1 kinase. The off-target effect is usually due to the lack of specificity of the drug, resulting in toxic side effects. Therefore, exploring the mechanisms to selectively inhibit HPK1 is critical for developing effective and safe inhibitors. In this study, two indazole compounds as HPK1 inhibitors with different selectivity towards JAK1 were used to investigate the selectivity mechanism using multiple computational methods, including conventional molecular dynamics simulations, binding free energy calculations and umbrella sampling simulations. The results indicate that the salt bridge between the inhibitor and residue Asp101 of HPK1 favors their selectivity towards HPK1 over JAK1. Information obtained from this study can be used to discover and design more potent and selective HPK1 inhibitors for immunotherapy. MDPI 2023-01-31 /pmc/articles/PMC9916865/ /pubmed/36768974 http://dx.doi.org/10.3390/ijms24032649 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ge, Huizhen
Tang, Chunchao
Pan, Yiting
Yao, Xiaojun
Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations
title Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations
title_full Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations
title_fullStr Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations
title_full_unstemmed Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations
title_short Theoretical Studies on Selectivity of HPK1/JAK1 Inhibitors by Molecular Dynamics Simulations and Free Energy Calculations
title_sort theoretical studies on selectivity of hpk1/jak1 inhibitors by molecular dynamics simulations and free energy calculations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916865/
https://www.ncbi.nlm.nih.gov/pubmed/36768974
http://dx.doi.org/10.3390/ijms24032649
work_keys_str_mv AT gehuizhen theoreticalstudiesonselectivityofhpk1jak1inhibitorsbymoleculardynamicssimulationsandfreeenergycalculations
AT tangchunchao theoreticalstudiesonselectivityofhpk1jak1inhibitorsbymoleculardynamicssimulationsandfreeenergycalculations
AT panyiting theoreticalstudiesonselectivityofhpk1jak1inhibitorsbymoleculardynamicssimulationsandfreeenergycalculations
AT yaoxiaojun theoreticalstudiesonselectivityofhpk1jak1inhibitorsbymoleculardynamicssimulationsandfreeenergycalculations